Archive

DOJ Catch of the Week -- Novo Nordisk Inc.

Posted 09/8/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Novo Nordisk Inc. On Tuesday, the company agreed to pay $58.65 million to settle charges it violated the False Claims Act and Food, Drug, and Cosmetic Act by failing to comply with the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for its Type II diabetes medication Victoza. The New Jersey based...

Tagged in: Catch of the Week, FCA Federal, FDA Fraud, Pharma Fraud,

Two Bay Area Companies for Developmentally Disabled Settle Whistleblower Charges of Overbilling

Posted 08/29/17

By the C|C Whistleblower Lawyer Team Two Bay Area companies and their owners agreed to pay roughly $2 million to settle charges they violated the False Claims Act by overbilling the government in a program designed to serve Californians with developmental disabilities. The government, and the whistleblower who originated the action -- Beverly McCaffery -- alleged that Alternative Learning Center, its president...

Tagged in: FCA Federal, Healthcare Fraud, Whistleblower Rewards,

Eye Surgery Provider Settles FCA Kickback Allegations for $12M

Posted 08/23/17

By the C|C Whistleblower Lawyer Team Sightpath Medical, Inc., its parent TLC Vision Corp., and its former CEO James Tiffany have agreed to pay $12 million to resolve allegations, originally brought by a whistleblower, that they defrauded the government by billing it for eye surgery products and services tainted by illegal kickbacks to physicians. According to the Justice Department’s press release, Sightpath...

Tagged in: Anti-Kickback and Stark, FCA Federal, Provider Fraud, Whistleblower Case, Whistleblower Rewards,

Mylan Agrees to Pay $465 Million in a False Claims Act Settlement

Posted 08/21/17

By the C|C Whistleblower Lawyer Team Last Friday, the Department of Justice (“DOJ”) announced a $465 million settlement with Mylan, Inc. to resolve claims that it violated the False Claim Act. The suit was brought by a whistleblower under the False Claims Act qui tam provisions and involved the alleged improper misclassification of the EpiPen as a generic drug to avoid paying rebates owed mainly to Medicaid....

Tagged in: Drug and DME Pricing, Medicaid, Pharma Fraud, Whistleblower Case, Whistleblower Eligibility, Whistleblower Rewards,

DOJ Catch of the Week -- Mylan

Posted 08/18/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Mylan Inc. and Mylan Specialty L.P. Yesterday, the pharmaceutical companies agreed to pay $465 million to settle charges they violated the False Claims Act by purposely misclassifying EpiPen as a generic drug to avoid paying higher Medicaid rebates. In announcing the settlement, the government stressed its "unwavering...

Tagged in: Catch of the Week, Drug and DME Pricing, FCA Federal, Medicaid, Pharma Fraud, Whistleblower Eligibility, Whistleblower Rewards,

Rehab Clinics Allegedly Paying Kickbacks to “Body Brokers”

Posted 08/17/17

By the C|C Whistleblower Lawyer Team With the rise of the nation’s opioid crises, more opportunities for corruption and fraud have developed. An industry of patient brokering or “body brokering” has been born. Body brokers are paid kickbacks by rehab clinics in exchange for their recruiting of patients. Patients with good insurance are the most appealing recruits. Kickbacks are also being paid between...

Tagged in: Anti-Kickback and Stark, Healthcare Fraud, Provider Fraud,

Martin Shkreli is Found Guilty of Fraud

Posted 08/7/17

By the C|C Whistleblower Lawyer Team A recent New York Times story details the reaction to a federal jury finding Martin Shkreli guilty on three counts of fraud. Shkreli faces up to twenty years in prison for each of the first two counts and five years in prison on the final count with sentencing pending. The jury spent five days deliberating before coming to its three guilty verdicts and acquitting Shkreli on five...

Tagged in: Pharma Fraud,

Celgene to Pay $280M to Resolve Fraud Allegations

Posted 07/26/17

By the C|C Whistleblower Lawyer Team Pharmaceutical manufacturer Celgene Corp. agreed to pay $280 million to settle claims that it illegally promoted two cancer drugs, Thalomid and Revlimid, for unapproved uses. The case was filed by a former Celgene sales representative under the False Claims Act, which allows individuals to sue to recover government dollars and share in any recovery. The New York Times reports...

Tagged in: Anti-Kickback and Stark, FCA Federal, FCA State, Healthcare Fraud, Medicaid, Medicare, Off-Label and Unapproved Use, Pharma Fraud, Whistleblower Case, Whistleblower Rewards,

DOJ Catch of The Week -- Foundations Health Solutions

Posted 07/21/17

By the C|C Whistleblower Lawyer Team This week's Department of Justice "Catch of the Week" goes to Foundations Health Solutions Inc., Olympia Therapy Inc. and Tridia Hospice Care Inc. On Monday, these Ohio-based companies, comprising one of the largest nursing home operations in the state, and their executives Brian Colleran and Daniel Parker, agreed to pay roughly $19.5 million to resolve allegations that they...

Tagged in: Anti-Kickback and Stark, Catch of the Week, FCA Federal, Home Health and Hospice, Lack of Medical Necessity, Whistleblower Rewards,

Aftershocks of the Feds' Big Bust: Lessons Learned

Posted 07/18/17

By the C|C Whistleblower Lawyer Team Listen to RAC Monitor's broadcast program, "Aftershocks of the Feds' Big Bust: Lessons Learned," featuring Constantine Cannon Partner, Mary Inman. Ms. Inman discusses the DOJ's recent Health Care Fraud Takedown and the prosecution of medical professionals involved in opioid-related crimes as a DOJ health care enforcement priority (at 21:30 of the broadcast). Click here for more.

Tagged in: CC Lawyers, Healthcare Fraud, Risk Adjustment Fraud,

Contact

Click here for a confidential contact or call:

DOJ Catch of the Week -- Novo Nordisk Inc.

Two Bay Area Companies for Developmentally Disabled Settle Whistleblower Charges of Overbilling

Eye Surgery Provider Settles FCA Kickback Allegations for $12M

Mylan Agrees to Pay $465 Million in a False Claims Act Settlement

DOJ Catch of the Week -- Mylan

Rehab Clinics Allegedly Paying Kickbacks to “Body Brokers”

Martin Shkreli is Found Guilty of Fraud

Celgene to Pay $280M to Resolve Fraud Allegations

DOJ Catch of The Week -- Foundations Health Solutions

Aftershocks of the Feds' Big Bust: Lessons Learned

Newsletter

Subscribe to receive email updates from the Constantine Cannon blogs

Sign up for: